🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 18 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 28/06/2013 | 22,78 | 23,74 | 22,77 | 23,33 | +2,41% | 4,27% | 852.956 |
| 27/06/2013 | 22,91 | 22,99 | 22,46 | 22,78 | +0,36% | 2,29% | 298.639 |
| 26/06/2013 | 22,69 | 22,92 | 22,54 | 22,70 | +1,25% | 1,68% | 396.582 |
| 25/06/2013 | 22,91 | 22,91 | 21,97 | 22,42 | +0,06% | 4,11% | 394.178 |
| 24/06/2013 | 21,47 | 22,79 | 20,75 | 22,41 | +3,22% | 9,47% | 402.032 |
| 21/06/2013 | 22,45 | 22,45 | 21,37 | 21,71 | -0,71% | 4,81% | 1.323.597 |
| 20/06/2013 | 19,88 | 23,30 | 19,56 | 21,87 | +8,41% | 18,83% | 1.130.115 |
| 19/06/2013 | 20,33 | 20,36 | 19,60 | 20,17 | -0,65% | 3,71% | 186.108 |
| 18/06/2013 | 19,61 | 20,48 | 19,26 | 20,30 | +3,53% | 6,23% | 231.473 |
| 17/06/2013 | 20,85 | 20,85 | 19,25 | 19,61 | -4,50% | 7,72% | 331.020 |
| 14/06/2013 | 21,06 | 21,12 | 20,48 | 20,53 | -2,60% | 3,05% | 220.733 |
| 13/06/2013 | 20,15 | 21,09 | 19,89 | 21,08 | +4,78% | 5,94% | 467.755 |
| 12/06/2013 | 20,37 | 20,49 | 19,79 | 20,12 | -0,15% | 3,46% | 177.933 |
| 11/06/2013 | 19,76 | 20,46 | 19,49 | 20,15 | +0,94% | 4,89% | 222.336 |
| 10/06/2013 | 20,27 | 20,41 | 19,76 | 19,96 | -0,53% | 3,17% | 234.840 |
| 07/06/2013 | 19,63 | 20,26 | 19,47 | 20,07 | +3,18% | 4,04% | 253.434 |
| 06/06/2013 | 19,03 | 19,48 | 18,76 | 19,45 | +2,06% | 3,74% | 237.725 |
| 05/06/2013 | 19,83 | 19,92 | 18,75 | 19,06 | -3,93% | 5,88% | 510.556 |
| 04/06/2013 | 19,93 | 20,09 | 19,35 | 19,84 | -0,63% | 3,76% | 1.749.835 |
| 03/06/2013 | 19,16 | 20,10 | 18,53 | 19,96 | +6,99% | 8,20% | 1.099.658 |
| 31/05/2013 | 18,47 | 19,18 | 18,47 | 18,66 | +0,61% | 3,82% | 400.109 |
| 30/05/2013 | 17,67 | 18,87 | 17,59 | 18,55 | +5,88% | 7,27% | 581.568 |
| 29/05/2013 | 16,79 | 17,57 | 16,71 | 17,52 | +3,46% | 5,16% | 436.176 |
| 28/05/2013 | 17,47 | 17,47 | 16,73 | 16,93 | -1,20% | 4,21% | 205.024 |
| 24/05/2013 | 17,37 | 17,40 | 17,06 | 17,14 | -1,72% | 2,01% | 53.059 |
| 23/05/2013 | 16,77 | 17,74 | 16,41 | 17,44 | +2,08% | 7,89% | 206.787 |
| 22/05/2013 | 17,38 | 17,62 | 16,69 | 17,08 | -1,30% | 5,38% | 251.511 |
| 21/05/2013 | 17,26 | 17,42 | 17,19 | 17,31 | +0,62% | 1,34% | 197.810 |
| 20/05/2013 | 17,42 | 17,78 | 17,16 | 17,20 | -1,57% | 3,54% | 159.018 |
| 17/05/2013 | 16,79 | 17,57 | 16,77 | 17,47 | +4,95% | 4,76% | 214.802 |